Revolutionizing Cornea Repair
BioLattice Ophthalmics is an award-winning tissue engineering company founded by Amelia Zellander, PhD (tissue engineer and pharmaceutical scientist) and Linda Alunkal, MBA. The company is developing CorneaClear, a synthetic corneal implant designed as a true alternative to donor corneas. With 2 million people suffering from corneal blindness annually and only 1 in 70 patients obtaining donor tissue, BioLattice's engineered cornea also offers corrective vision capabilities. The company has received funding from Life Sciences Greenhouse Investments (LSGI) and won multiple pitch competitions including HiveBio's Silicon Valley competition ($20K) and the Startup of the Year award. Based in Philadelphia and backed by federal grants before transitioning to VC funding.
Create a free account to see funding visualizations and detailed round data.
Create Free AccountOct 2024
Create a free account to see which investors have funded this company.
Create Free Account
Asymchem provides R&D and one-stop production services to the world's top pharmaceutical companies.
South Korean biotech company and global leader in medical aesthetics, manufacturing botulinum tox...
Global full-service clinical research organization (CRO) and scientific advisory partner for biot...
Global clinical research organization specializing in early-stage clinical trials and bioanalytic...
Healthcare company applying technology to drug development by building nimble biotech subsidiarie...
Neuralink is building a brain-computer interface for medical needs and greater human potential.
